Abstract
Dr Mark A Wainberg is Professor of Medicine and Microbiology and Immunology at McGill University (Montreal, Canada) and Director of the McGill University AIDS Centre. He served as President of the International AIDS Society between 1998 and 2000 with responsibilities that included organization of the XIII International Congress on AIDS (Durban, South Africa) in 2000. He was also co-Chair of the XVI International AIDS Conference that took place in Toronto, Canada, in August 2006. He is well known for his initial identification of 3TC as an antiviral drug, in collaboration with BioChem Pharma Inc, in 1989, as well as for multiple contributions to the field of HIV drug resistance. Dr Wainberg now works on efforts to achieve a cure for HIV infection. Among other honors, Dr Wainberg is an Officer of the Order of Canada and a Chevalier in the Legion d'Honneur of France, as well as the recipient of a number of honorary doctorates. Dr Wainberg is an author of over 500 research papers and 100 reviews and commentary articles that have appeared in scientific literature. He is co-Editor-in-Chief of Retrovirology, co-Editor-in-Chief of Journal of the International AIDS Society, and is a member of the editorial committees of multiple other journals. More than 30 students have obtained their PhD degrees under his tutelage.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
